(Q39490160)

English

Phase I trial of the diphtheria toxin/interleukin-2 fusion protein DAB486IL-2: efficacy in mycosis fungoides and other non-Hodgkin's lymphomas

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Phase I trial of the diphtheria toxin/interleukin-2 fusion protein DAB486IL-2: efficacy in mycosis fungoides and other non-Hodgkin's lymphomas (English)

1 reference

Europe PubMed Central

12 September 2017

phase I clinical trial

0 references

mycosis fungoides

1 reference

based on heuristic

inferred from title

author name string

Kuzel TM

1

1 reference

Europe PubMed Central

12 September 2017

Rosen ST

2

1 reference

Europe PubMed Central

12 September 2017

Gordon LI

3

1 reference

Europe PubMed Central

12 September 2017

Winter J

4

1 reference

Europe PubMed Central

12 September 2017

Samuelson E

5

1 reference

Europe PubMed Central

12 September 2017

Kaul K

6

1 reference

Europe PubMed Central

12 September 2017

Roenigk HH

7

1 reference

Europe PubMed Central

12 September 2017

Nylen P

8

1 reference

Europe PubMed Central

12 September 2017

Woodworth T

9

1 reference

Europe PubMed Central

12 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 1993

1 reference

Europe PubMed Central

12 September 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

12 September 2017

11

1 reference

Europe PubMed Central

12 September 2017

5-6

1 reference

Europe PubMed Central

12 September 2017

369-377

1 reference

Europe PubMed Central

12 September 2017

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067928

21 January 2018

Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067928

21 January 2018

Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067928

21 January 2018

Interleukin 2 receptor-targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells.

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067928

21 January 2018

Evaluation of serum levels of soluble interleukin-2 receptor in patients with chronic lymphoproliferative disorders of T-lymphocytes.

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067928

21 January 2018

Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk.

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067928

21 January 2018

Elevated serum levels of soluble Tac peptide in adult T-cell leukemia: correlation with clinical status during chemotherapy

1 reference

https://api.crossref.org/works/10.3109%2F10428199309067928

21 January 2018

Identifiers

10.3109/10428199309067928

1 reference

Europe PubMed Central

12 September 2017

release_67rnwj3nxfflhpiqybrnjhn66u

0 references

1 reference

Europe PubMed Central

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39490160&oldid=1830909670"